Comparison of Pain control method with two techniques, Intravenous patient Control Analgesia with drug Morphine (IVPCA morphine)and epidural infusion with drug Levobupivacaine with fentanyl after a surgery named Robotic assisted minimal invasive esophagectomy for Carcinoma Esophagus

Pain management after Robot-Assisted minimally invasive esophagectomy,comparison of analgesic efficacy of IV PCA morphine and epidural Levobupivacaine with fentanyl - NIL

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/064513

Enrollment

Registered

2024-03-20

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C159- Malignant neoplasm of esophagus, unspecified Health Condition 2: C159- Malignant neoplasm of esophagus, unspecified Health Condition 3: C159- Malignant neoplasm of esophagus, unspecified

Interventions

Intervention1: intravenous patient control analgesia with morphine: patient not having epidural catheter placed in OT and intravenous patient control analgesia with morphine used. Each dose of 0.5mg/1

Eligibility

Inclusion criteria

Inclusion criteria: Patient undergoing Robotic esophagectomy Patients willing to use IV Patient control Analgesia

Exclusion criteria

Exclusion criteria: Patient refusal for epidural catheter placement ASA physical status 3 or more

Design outcomes

Primary

Measure	Time frame
Compare VAS pain score to assess postoperative analgesia between two study groupTimepoint: Every 6 hourly on postoperative day then every 12 hourly for next 4 days till epidural catheter in situ or ivPCA morphine till 4th postop day	—

Secondary

Measure	Time frame
Requirement of rescue analgesia doses and total volume of drug used for epidural infusion and in IVPCA groupTimepoint: Every 6 hourly on postoperative day then every 12 hourly for next 4 days till epidural catheter in situ or ivPCA morphine till 4th postop day	—

Countries

India

Contacts

Public ContactDr Vishal Bhatnagar

Rajiv Gandhi Cancer Institute & Research Center New Delhi

drvishalbhatnagar@yahoo.com9910950363

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026